Access our Portals! Diabetes Portal
Obesity Portal
Cancer Portal
Portada Espanol
Events
| « | February 2012 | » | ||||
|---|---|---|---|---|---|---|
| S | M | T | W | T | F | S |
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | |||
User login
Navigation
QuickStats: Percentage of Men Aged >40 Years* with Prostate-Specific Antigen (PSA) Levels of >2.5 and >4.0 ng/mL, by Race...
To Access Full Article Click Here
Summary
QuickStats: Percentage of Men Aged >40 Years* with Prostate-Specific Antigen (PSA) Levels of >2.5 and >4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004 Although screening for prostate cancer using the PSA test is common, clinicians are divided over whether the screening test is effective and whether a lower PSA threshold should be used to refer patients for prostate biopsy to rule out cancer. A PSA level of >4.0 ng/mL is the common threshold; however, certain researchers have recommended lowering the level to >2.5 ng/mL. During 2001--2004, approximately 6.2% (3.6 million) of men aged >40 years in the United States had a PSA level of >4.0 ng/mL, and approximately 13.1% had a PSA of >2.5 ng/mL. Differences among racial/ethnic groups tested were not statistically significant.
QuickStats: Percentage of Men Aged >40 Years* with Prostate-Specific Antigen (PSA) Levels of >2.5 and >4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004 Although screening for prostate cancer using the PSA test is common, clinicians are divided over whether the screening test is effective and whether a lower PSA threshold should be used to refer patients for prostate biopsy to rule out cancer. A PSA level of >4.0 ng/mL is the common threshold; however, certain researchers have recommended lowering the level to >2.5 ng/mL. During 2001--2004, approximately 6.2% (3.6 million) of men aged >40 years in the United States had a PSA level of >4.0 ng/mL, and approximately 13.1% had a PSA of >2.5 ng/mL. Differences among racial/ethnic groups tested were not statistically significant.
